« Previous
Next »
American Journal of Cardiology
Volume 105, Issue 3
, Pages
283-287
, 1 February 2010
Comparison of 80 versus 10 mg of Atorvastatin on Occurrence of Cardiovascular Events After the First Event (from the Treating to New Targets [TNT] Trial)
To access this article, please choose from the options below
The TNT study was funded by Pfizer, Inc., New York, New York.
PII: S0002-9149(09)02396-0
doi: 10.1016/j.amjcard.2009.09.025
© 2010 Elsevier Inc. All rights reserved.
« Previous
Next »
American Journal of Cardiology
Volume 105, Issue 3
, Pages
283-287
, 1 February 2010
